Malignant Signature May Help Identify Patients Likely To Respond To Therapy

A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. The finding could lead to a personalized approach to treatment for a variety of solid tumors that are currently resistant to therapies.

Read the whole article on Science Daily

More from Science Daily